Sang T. Jung

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Precision Fc remodeling via glycosylation-competent CHO display enables ultra-selective FcγRIIIa targeting and enhanced antitumor activity.

Precision Fc remodeling via glycosylation-competent CHO display enables ultra-selective FcγRIIIa targeting and enhanced antitumor activity.

Journal: Journal of biological engineering
Published: January 01, 2026

Reprogramming the SARS-CoV-1 Neutralizing Antibody S230 to SARS-CoV-2 via Directed Evolution and Molecular Docking-Based Binding Mode Analysis.

Reprogramming the SARS-CoV-1 Neutralizing Antibody S230 to SARS-CoV-2 via Directed Evolution and Molecular Docking-Based Binding Mode Analysis.

Journal: ACS synthetic biology
Published: November 14, 2025

Repositioning neutrophils in cancer immunotherapy: From innate defenders to antibody-driven effectors.

Repositioning neutrophils in cancer immunotherapy: From innate defenders to antibody-driven effectors.

Journal: Seminars in hematology
Published: October 13, 2025

Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV-2 through Directed Evolution of SARS-CoV-1 Antibodies.

Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV-2 through Directed Evolution of SARS-CoV-1 Antibodies.

Journal: Molecular pharmaceutics
Published: July 24, 2025

Directed evolution-driven reprogramming of PD-L1 for compact and tunable checkpoint modulation.

Directed evolution-driven reprogramming of PD-L1 for compact and tunable checkpoint modulation.

Journal: Journal of biological engineering
Published: July 07, 2025

Directed evolution and modular integration of a high-affinity ICOS-L variant for potent T cell-mediated tumor elimination.

Directed evolution and modular integration of a high-affinity ICOS-L variant for potent T cell-mediated tumor elimination.

Journal: Journal of biological engineering
Published: April 29, 2025

Design of an Fc Mutation to Abrogate Fcγ Receptor Binding Based on Residue Interaction Network Analysis.

Design of an Fc Mutation to Abrogate Fcγ Receptor Binding Based on Residue Interaction Network Analysis.

Journal: ACS synthetic biology
Published: April 29, 2025

Engineered neutrophil engagers overcome IgA limitations and reprogram resting neutrophils for cancer immunotherapy.

Engineered neutrophil engagers overcome IgA limitations and reprogram resting neutrophils for cancer immunotherapy.

Journal: Journal of biological engineering
Published: April 14, 2025

Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential.

Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential.

Journal: Journal of biological engineering
Published: March 18, 2025

Advanced human FcRn knock-in mice for pharmacokinetic profiling of therapeutic antibodies.

Advanced human FcRn knock-in mice for pharmacokinetic profiling of therapeutic antibodies.

Journal: Scientific reports
Published: December 24, 2024

Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants.

Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants.

Journal: Journal of nanobiotechnology
Published: September 20, 2024

Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs.

Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs.

Journal: Molecular pharmaceutics
Published: July 26, 2024
Showing 1-12 of 51

Last Updated: 09/26/2026